Literature DB >> 21510013

Instrumental comparison of the determination of Cr³+ uptake by human transferrin.

C Derrick Quarles1, Julia L Brumaghim, R Kenneth Marcus.   

Abstract

UV-VIS absorbance, inductively coupled plasma-optical emission spectroscopy (ICP-OES), and particle beam/hollow cathode-optical emission spectroscopy (PB/HC-OES) are presented as techniques for determining Cr³+ loading into transferrin (Tf), with and without Fe³+. The methods are compared based on loading percentages (i.e. 100% loading would be equal to 2 M(n+): 1 Tf) determined for Cr³+ loading into apo-transferrin. Spectral interferences and overlapping LMCT bands cause inaccurate chromium (qualitative) and iron (qualitative and quantitative) results for the UV-VIS absorbance method. The ICP-OES and PB/HC-OES methods are in good agreement providing evidence that the PB/HC-OES method is a valid technique for investigating metal-protein complexes. Maximum Cr³+ loading into apo-transferrin over a 24 h period was determined to be 26.8 3.5% by the ICP-OES method and 25.3 2.2% by the PB/HC-OES method. Loading percentages were increased to 49.7 1.9% (ICP-OES) and 55.7 3.2% (PB/HC-OES) when the metal-transferrin solution was allowed to incubate for up to 10 days. Under non-excess carbonate conditions the Cr³+ loading is elevated over a 24 h incubation time, but under physiological conditions the loading is inhibited. Equal loading of Fe³+ and Cr³+ into apo-transferrin was achieved when chromium was at a level more than 5 times in excess of iron. Inhibition of Cr³+ loading was only observed when an excess of Fe³+ was available to bind into apo-transferrin. The ability for Cr³+ to displace Fe3+ from holo-transferrin was observed as small amounts of Cr³+ were loaded into the once occupied metal binding site.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21510013     DOI: 10.1039/c0mt00032a

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  6 in total

1.  Competitive binding of Fe3+, Cr3+, and Ni2+ to transferrin.

Authors:  C Derrick Quarles; R Kenneth Marcus; Julia L Brumaghim
Journal:  J Biol Inorg Chem       Date:  2011-06-17       Impact factor: 3.358

2.  Significance of conformation changes during the binding and release of chromium(III) from human serum transferrin.

Authors:  Kyle C Edwards; Hannah Kim; Riley Ferguson; Molly M Lockart; John B Vincent
Journal:  J Inorg Biochem       Date:  2020-02-15       Impact factor: 4.155

3.  The Effects of Supplementary Cr3 (Chromium(III) Propionate Complex) on the Mineral Status in Healthy Female Rats.

Authors:  Halina Staniek; Zbigniew Krejpcio
Journal:  Biol Trace Elem Res       Date:  2017-03-10       Impact factor: 3.738

4.  The Combined Effects of Iron Excess in the Diet and Chromium(III) Supplementation on the Iron and Chromium Status in Female Rats.

Authors:  Halina Staniek; Rafał W Wójciak
Journal:  Biol Trace Elem Res       Date:  2017-11-21       Impact factor: 3.738

5.  Chromium(III) Glycinate Complex Supplementation Improves the Blood Glucose Level and Attenuates the Tissular Copper to Zinc Ratio in Rats with Mild Hyperglycaemia.

Authors:  Ewelina Król; Zbigniew Krejpcio; Monika Okulicz; Hanna Śmigielska
Journal:  Biol Trace Elem Res       Date:  2019-03-02       Impact factor: 3.738

6.  Many-Body Study of Iron(III)-Bound Human Serum Transferrin.

Authors:  Hovan Lee; Cedric Weber; Edward B Linscott
Journal:  J Phys Chem Lett       Date:  2022-05-12       Impact factor: 6.888

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.